IBUPROFEN SODIUM

IBUPROFEN SODIUM was reported 43007 times

IBUPROFEN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SWOLLEN JOINT COUNT 33 0.1320
1 GRIP STRENGTH 27 0.1179
2 PRODUCT COATING ISSUE 83 0.0813
3 PRODUCT DIFFICULT TO SWALLOW 61 0.0600
4 POOR QUALITY DRUG ADMINISTERED 358 0.0553
5 C-REACTIVE PROTEIN 41 0.0442
6 FOREIGN BODY 172 0.0429
7 FOREIGN BODY IN RESPIRATORY TRACT 56 0.0427
8 DEEP VEIN THROMBOSIS POSTOPERATIVE 82 0.0409
9 REACTION TO DRUG EXCIPIENTS 75 0.0345
10 DRUG EFFECT DELAYED 146 0.0322
11 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 939 0.0320
12 RETINITIS 53 0.0307
13 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 62 0.0299
14 PRODUCT SHAPE ISSUE 27 0.0286
15 FACET JOINT SYNDROME 92 0.0282
16 PRODUCT COMMINGLING 30 0.0282
17 BLOOD PRESSURE DIASTOLIC ABNORMAL 70 0.0275
18 BLOOD PRESSURE SYSTOLIC ABNORMAL 68 0.0275
19 DISLOCATION OF VERTEBRA 60 0.0263
20 LUPUS VULGARIS 33 0.0262
21 X-RAY ABNORMAL 45 0.0251
22 SWOLLEN JOINT COUNT INCREASED 68 0.0213
23 PORPHYRIA ACUTE 29 0.0202
24 PRODUCT USED FOR UNKNOWN INDICATION 25 0.0199
25 SKIN PAPILLOMA 79 0.0197
26 RHEUMATIC FEVER 86 0.0193
27 PERIPHERAL VENOUS DISEASE 78 0.0191
28 BILIARY DYSKINESIA 31 0.0183
29 FOREIGN BODY IN THROAT 57 0.0181
30 PRODUCT TASTE ABNORMAL 238 0.0176
31 PRE-EXISTING CONDITION IMPROVED 105 0.0168
32 BONE EROSION 59 0.0167
33 C-REACTIVE PROTEIN ABNORMAL 101 0.0157
34 PRODUCT SIZE ISSUE 84 0.0156
35 DUODENAL ULCER PERFORATION 116 0.0156
36 DRUG EFFECT INCOMPLETE 537 0.0148
37 RHEUMATOID FACTOR POSITIVE 85 0.0147
38 THERAPEUTIC PRODUCT EFFECT VARIABLE 57 0.0147
39 ORAL DISCOMFORT 200 0.0144
40 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 90 0.0138
41 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 99 0.0138
42 AUTOIMMUNE DISORDER 134 0.0137
43 PRODUCT COLOUR ISSUE 70 0.0136
44 PRODUCT PHYSICAL ISSUE 271 0.0134
45 MUSCLE INJURY 111 0.0134
46 CHOLECYSTITIS CHRONIC 88 0.0131
47 LIP DRY 116 0.0128
48 EPIGASTRIC DISCOMFORT 49 0.0125
49 THROMBOPHLEBITIS SUPERFICIAL 38 0.0125
50 FEAR OF DISEASE 22 0.0124
51 BLOOD PRESSURE DIASTOLIC INCREASED 55 0.0119
52 GRIP STRENGTH DECREASED 103 0.0117
53 THERAPEUTIC PRODUCT EFFECT DELAYED 53 0.0116
54 BREAST CANCER STAGE III 75 0.0116
55 OESOPHAGEAL PAIN 45 0.0114
56 COELIAC DISEASE 111 0.0113
57 EXOSTOSIS 103 0.0113
58 VITAMIN B12 DECREASED 32 0.0111
59 JOINT RANGE OF MOTION DECREASED 146 0.0109
60 GASTRIC ULCER HAEMORRHAGE 60 0.0108
61 MENOPAUSAL SYMPTOMS 25 0.0107
62 BURSITIS 129 0.0106
63 CARTILAGE INJURY 26 0.0105
64 SEDATION 275 0.0105
65 SCIATICA 165 0.0103
66 PRODUCT LABEL ISSUE 70 0.0103
67 ULCER HAEMORRHAGE 69 0.0102
68 GLOSSODYNIA 228 0.0102
69 HELICOBACTER INFECTION 103 0.0100
70 DRUG EFFECT LESS THAN EXPECTED 148 0.0100
71 REACTION TO EXCIPIENT 23 0.0100
72 TONGUE DISCOMFORT 42 0.0099
73 SYNOVIAL CYST 45 0.0097
74 HYPOAESTHESIA ORAL 146 0.0097
75 THROAT IRRITATION 433 0.0096
76 FOLLICULITIS 101 0.0096
77 IRRITABLE BOWEL SYNDROME 205 0.0096
78 GASTRIC HAEMORRHAGE 108 0.0094
79 GASTRIC ULCER 175 0.0092
80 NIGHTMARE 317 0.0092
81 GASTRIC DISORDER 311 0.0091
82 PRODUCT USE COMPLAINT 141 0.0089
83 POOR QUALITY PRODUCT ADMINISTERED 94 0.0089
84 DRUG TOLERANCE DECREASED 25 0.0089
85 EXPIRED DRUG ADMINISTERED 44 0.0089
86 HANGOVER 31 0.0088
87 BLOOD PRESSURE DIASTOLIC DECREASED 65 0.0088
88 HYPERCHOLESTEROLAEMIA 84 0.0087
89 INTERVERTEBRAL DISC DEGENERATION 80 0.0086
90 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 58 0.0085
91 CONGENITAL ANOMALY 66 0.0085
92 PRODUCT ODOUR ABNORMAL 89 0.0085
93 PARANASAL SINUS DISCOMFORT 32 0.0084
94 PLANTAR FASCIITIS 28 0.0083
95 TENDON DISORDER 54 0.0083
96 PRODUCT FORMULATION ISSUE 54 0.0082
97 THERAPEUTIC RESPONSE UNEXPECTED 367 0.0082
98 SYNOVITIS 147 0.0081
99 ANKYLOSING SPONDYLITIS 106 0.0080
100 FOOT DEFORMITY 88 0.0079
101 ABDOMINAL DISCOMFORT 1318 0.0078
102 HAND DEFORMITY 103 0.0078
103 WOUND INFECTION 85 0.0078
104 ROSACEA 36 0.0077
105 DYSPEPSIA 756 0.0077
106 EAR DISORDER 35 0.0076
107 INFUSION SITE PRURITUS 24 0.0076
108 BODY TEMPERATURE DECREASED 74 0.0075
109 CHOKING 146 0.0075
110 MATERNAL EXPOSURE TIMING UNSPECIFIED 28 0.0074
111 TENSION HEADACHE 32 0.0074
112 NEPHROLITHIASIS 340 0.0074
113 SNORING 28 0.0074
114 WEIGHT FLUCTUATION 77 0.0074
115 DIVERTICULUM 52 0.0073
116 PRODUCT USE IN UNAPPROVED INDICATION 1808 0.0073
117 BODY HEIGHT DECREASED 78 0.0073
118 CYTOLYTIC HEPATITIS 24 0.0072
119 INTENTIONAL PRODUCT MISUSE 629 0.0072
120 CORONARY ARTERY STENOSIS 36 0.0072
121 WALKING AID USER 47 0.0071
122 NERVE COMPRESSION 65 0.0070
123 EAR INFECTION 187 0.0070
124 PEMPHIGUS 87 0.0070
125 SPONDYLITIS 25 0.0069
126 LOWER LIMB FRACTURE 132 0.0069
127 ULCER 108 0.0068
128 DECREASED INTEREST 40 0.0068
129 OESOPHAGEAL DISORDER 26 0.0067
130 MUSCLE STRAIN 58 0.0067
131 SEASONAL ALLERGY 94 0.0066
132 MULTIPLE ALLERGIES 51 0.0065
133 SPINAL OSTEOARTHRITIS 57 0.0065
134 FEELING OF BODY TEMPERATURE CHANGE 38 0.0065
135 NIGHT SWEATS 208 0.0064
136 MELANOCYTIC NAEVUS 28 0.0064
137 BONE LESION 23 0.0064
138 MUSCULOSKELETAL PAIN 332 0.0063
139 SUSPECTED COUNTERFEIT PRODUCT 25 0.0063
140 EXPIRED PRODUCT ADMINISTERED 210 0.0063
141 THERMAL BURN 44 0.0062
142 SINUSITIS 635 0.0062
143 LIP SWELLING 206 0.0062
144 FIBROMYALGIA 150 0.0062
145 GINGIVITIS 33 0.0061
146 AORTIC VALVE INCOMPETENCE 26 0.0061
147 EAR PAIN 118 0.0061
148 SENSATION OF FOREIGN BODY 51 0.0060
149 NEPHROGENIC ANAEMIA 28 0.0060
150 MUSCULOSKELETAL STIFFNESS 529 0.0060
151 DYSGEUSIA 448 0.0060
152 OBESITY 96 0.0060
153 EYE SWELLING 223 0.0060
154 POST-TRAUMATIC STRESS DISORDER 40 0.0060
155 RED BLOOD CELL SEDIMENTATION RATE INCREASED 66 0.0060
156 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 327 0.0060
157 CONTRAINDICATED PRODUCT ADMINISTERED 180 0.0059
158 DRUG TOLERANCE 30 0.0059
159 JOINT DISLOCATION 62 0.0059
160 INFLAMMATORY MARKER INCREASED 29 0.0058
161 INCREASED UPPER AIRWAY SECRETION 30 0.0058
162 MIDDLE INSOMNIA 109 0.0058
163 DUODENAL ULCER 41 0.0058
164 MIGRAINE 554 0.0058
165 BLOOD CHOLESTEROL INCREASED 269 0.0058
166 ABDOMINAL PAIN UPPER 1185 0.0057
167 INFLAMMATION 297 0.0057
168 LUPUS-LIKE SYNDROME 52 0.0057
169 ARTHROPATHY 318 0.0057
170 SENSITIVITY TO WEATHER CHANGE 30 0.0057
171 ODYNOPHAGIA 34 0.0057
172 GAIT INABILITY 190 0.0057
173 MUSCLE FATIGUE 24 0.0057
174 HEPATIC PAIN 24 0.0056
175 GOITRE 23 0.0056
176 VITAMIN D DECREASED 48 0.0056
177 HYPERLIPIDAEMIA 67 0.0056
178 OSTEOARTHRITIS 236 0.0056
179 INJURY 391 0.0056
180 CHEILITIS 30 0.0055
181 PHARYNGITIS STREPTOCOCCAL 60 0.0055
182 BLOOD PRESSURE FLUCTUATION 133 0.0055
183 TOOTH INFECTION 73 0.0055
184 SWELLING FACE 360 0.0055
185 IMPAIRED HEALING 181 0.0055
186 DISCOMFORT 336 0.0055
187 NECK PAIN 306 0.0055
188 OROPHARYNGEAL PAIN 506 0.0055
189 PHARYNGEAL OEDEMA 84 0.0055
190 THROAT TIGHTNESS 147 0.0054
191 JOINT SWELLING 655 0.0054
192 INJECTION SITE INFLAMMATION 27 0.0054
193 SINUS DISORDER 107 0.0054
194 SINUS HEADACHE 32 0.0054
195 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 383 0.0054
196 TENDERNESS 56 0.0054
197 MUSCLE SPASTICITY 66 0.0054
198 ARTHRITIS 421 0.0053
199 JOINT STIFFNESS 140 0.0053
200 CHAPPED LIPS 23 0.0053
201 BLOOD PRESSURE SYSTOLIC INCREASED 103 0.0053
202 DEFAECATION URGENCY 37 0.0053
203 LIGAMENT SPRAIN 52 0.0053
204 DYSPHAGIA 498 0.0052
205 GASTRITIS 138 0.0052
206 DRUG INEFFECTIVE 6911 0.0052
207 PERICARDITIS 88 0.0052
208 VISUAL DISTURBANCE 30 0.0052
209 MOUTH SWELLING 30 0.0052
210 PSORIATIC ARTHROPATHY 211 0.0052
211 MUSCULOSKELETAL CHEST PAIN 80 0.0052
212 FAECES DISCOLOURED 112 0.0052
213 INFLAMMATORY BOWEL DISEASE 50 0.0051
214 PERONEAL NERVE PALSY 29 0.0051
215 INTENTIONAL PRODUCT USE ISSUE 447 0.0051
216 RENAL DISORDER 237 0.0051
217 ENERGY INCREASED 30 0.0051
218 FRUSTRATION TOLERANCE DECREASED 41 0.0051
219 INITIAL INSOMNIA 52 0.0051
220 RHEUMATOID ARTHRITIS 575 0.0051
221 SKIN LACERATION 55 0.0051
222 MUSCULOSKELETAL DISCOMFORT 87 0.0050
223 FACIAL PAIN 45 0.0050
224 LIVER DISORDER 223 0.0050
225 HIATUS HERNIA 65 0.0050
226 HYPERHIDROSIS 644 0.0050
227 POOR QUALITY SLEEP 107 0.0050
228 GASTRITIS EROSIVE 23 0.0049
229 RENAL PAIN 52 0.0049
230 PAROSMIA 37 0.0049
231 DYSMENORRHOEA 65 0.0049
232 LIMB INJURY 133 0.0049
233 CHOKING SENSATION 27 0.0049
234 LIVER INJURY 120 0.0049
235 SINUS CONGESTION 66 0.0049
236 IRON DEFICIENCY ANAEMIA 45 0.0049
237 BACK INJURY 53 0.0049
238 ARTHROPOD BITE 36 0.0049
239 FREQUENT BOWEL MOVEMENTS 131 0.0048
240 FEELING DRUNK 36 0.0048
241 PRODUCT PACKAGING ISSUE 46 0.0048
242 FEELING JITTERY 92 0.0048
243 DRUG INTOLERANCE 465 0.0048
244 PRESCRIBED OVERDOSE 93 0.0048
245 UTERINE LEIOMYOMA 35 0.0048
246 NASAL DRYNESS 30 0.0048
247 CARPAL TUNNEL SYNDROME 67 0.0048
248 TENDONITIS 74 0.0048
249 SLEEP DISORDER 336 0.0048
250 JAW DISORDER 26 0.0047
251 ORAL PAIN 106 0.0047
252 SWELLING 443 0.0047
253 BONE DISORDER 86 0.0047
254 STOMATITIS 286 0.0047
255 HYPOAESTHESIA 704 0.0047
256 TONGUE DISORDER 34 0.0047
257 SCAR 80 0.0047
258 ROTATOR CUFF SYNDROME 60 0.0047
259 INTERVERTEBRAL DISC PROTRUSION 102 0.0047
260 PARAESTHESIA ORAL 67 0.0046
261 APHTHOUS ULCER 36 0.0046
262 JOINT EFFUSION 32 0.0046
263 TOOTHACHE 84 0.0046
264 HYPERSENSITIVITY 859 0.0046
265 TINNITUS 211 0.0046
266 DRY MOUTH 372 0.0046
267 MUSCULOSKELETAL DISORDER 87 0.0046
268 FEELING HOT 280 0.0046
269 MOBILITY DECREASED 328 0.0046
270 BURNING SENSATION 320 0.0046
271 EYELID OEDEMA 53 0.0046
272 DRUG SCREEN POSITIVE 36 0.0046
273 MICTURITION URGENCY 52 0.0045
274 PIGMENTATION DISORDER 28 0.0045
275 GINGIVAL PAIN 36 0.0045
276 INFLUENZA LIKE ILLNESS 372 0.0045
277 RECTAL HAEMORRHAGE 194 0.0045
278 MUSCLE TIGHTNESS 73 0.0045
279 PERIPHERAL SWELLING 694 0.0045
280 SNEEZING 101 0.0045
281 RETCHING 96 0.0045
282 STREPTOCOCCAL INFECTION 25 0.0045
283 UPPER-AIRWAY COUGH SYNDROME 37 0.0045
284 BLOOD PRESSURE INCREASED 686 0.0045
285 IMPAIRED DRIVING ABILITY 51 0.0045
286 HEART RATE ABNORMAL 25 0.0045
287 NASOPHARYNGITIS 825 0.0045
288 WOUND 125 0.0045
289 ROAD TRAFFIC ACCIDENT 187 0.0045
290 HEAD DISCOMFORT 79 0.0045
291 INCREASED TENDENCY TO BRUISE 41 0.0045
292 TRISMUS 23 0.0044
293 URTICARIA 745 0.0044
294 BOWEL MOVEMENT IRREGULARITY 34 0.0044
295 SPINAL PAIN 52 0.0044
296 INFUSION RELATED REACTION 294 0.0044
297 PANIC REACTION 32 0.0044
298 BACK DISORDER 72 0.0044
299 INFUSION SITE PAIN 57 0.0044
300 LOWER RESPIRATORY TRACT INFECTION 201 0.0044
301 NASAL DISCOMFORT 35 0.0044
302 VITAMIN D DEFICIENCY 43 0.0044
303 BACK PAIN 1020 0.0044
304 GASTROOESOPHAGEAL REFLUX DISEASE 353 0.0044
305 GALLBLADDER DISORDER 78 0.0044
306 ORAL DISORDER 32 0.0044
307 FEELING ABNORMAL 1046 0.0044
308 TEMPERATURE INTOLERANCE 45 0.0044
309 SCOLIOSIS 27 0.0044
310 BLISTER 244 0.0043
311 LYMPHOEDEMA 30 0.0043
312 HEARING IMPAIRED 26 0.0043
313 RIB FRACTURE 89 0.0043
314 HIP ARTHROPLASTY 66 0.0043
315 OVARIAN CYST 43 0.0043
316 SKIN WARM 25 0.0043
317 FOOD POISONING 23 0.0043
318 RESTLESS LEGS SYNDROME 78 0.0043
319 GASTROINTESTINAL DISORDER 384 0.0043
320 PANIC ATTACK 155 0.0042
321 URINE ODOUR ABNORMAL 25 0.0042
322 BLOOD DISORDER 34 0.0042
323 UPPER RESPIRATORY TRACT INFECTION 196 0.0042
324 PHOTOSENSITIVITY REACTION 70 0.0042
325 MENISCUS INJURY 26 0.0042
326 HYDROCEPHALUS 23 0.0042
327 GENERALISED ERYTHEMA 24 0.0042
328 TOXIC EPIDERMAL NECROLYSIS 64 0.0042
329 BLOOD URINE PRESENT 80 0.0042
330 OROPHARYNGEAL DISCOMFORT 38 0.0042
331 INSOMNIA 1114 0.0042
332 GASTROINTESTINAL PAIN 46 0.0042
333 HOT FLUSH 315 0.0042
334 FLATULENCE 237 0.0042
335 CARDIAC FLUTTER 27 0.0042
336 CONTUSION 402 0.0042
337 HEADACHE 2615 0.0042
338 DYSURIA 153 0.0042
339 NEURALGIA 101 0.0041
340 MITRAL VALVE INCOMPETENCE 47 0.0041
341 WRONG DRUG ADMINISTERED 37 0.0041
342 HEART RATE INCREASED 409 0.0041
343 DRUG EFFECT DECREASED 222 0.0041
344 DERMATITIS CONTACT 47 0.0041
345 RHINORRHOEA 266 0.0041
346 PARAESTHESIA 647 0.0041
347 PHARYNGITIS 51 0.0041
348 MAJOR DEPRESSION 30 0.0041
349 PAIN IN EXTREMITY 1209 0.0041
350 HAEMATEMESIS 104 0.0041
351 PAIN 2518 0.0041
352 ARTHRALGIA 1701 0.0041
353 CHOLELITHIASIS 134 0.0041
354 DENTAL CARIES 45 0.0041
355 PERIORBITAL SWELLING 23 0.0041
356 LUNG DISORDER 199 0.0041
357 MUSCLE SPASMS 744 0.0041
358 COLITIS ULCERATIVE 181 0.0040
359 EXTRA DOSE ADMINISTERED 164 0.0040
360 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 29 0.0040
361 ORAL HERPES 79 0.0040
362 PHOTOPHOBIA 76 0.0040
363 ATELECTASIS 39 0.0040
364 SCAB 46 0.0040
365 TRICUSPID VALVE INCOMPETENCE 32 0.0040
366 TOOTH ABSCESS 41 0.0040
367 LOCAL SWELLING 70 0.0040
368 ANKLE FRACTURE 62 0.0040
369 TOOTH DISORDER 89 0.0040
370 CHEST PAIN 739 0.0040
371 GAIT DISTURBANCE 763 0.0040
372 UPPER GASTROINTESTINAL HAEMORRHAGE 67 0.0040
373 JOINT INJURY 85 0.0040
374 SENSORY LOSS 32 0.0040
375 RASH PAPULAR 89 0.0040
376 HEART RATE DECREASED 139 0.0040
377 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 190 0.0040
378 GINGIVAL BLEEDING 54 0.0040
379 EYE PAIN 223 0.0039
380 MUSCLE DISORDER 32 0.0039
381 DYSGRAPHIA 26 0.0039
382 THERAPEUTIC RESPONSE CHANGED 25 0.0039
383 DRY THROAT 40 0.0039
384 BALANCE DISORDER 340 0.0039
385 SLEEP APNOEA SYNDROME 75 0.0039
386 CARDIAC MURMUR 34 0.0039
387 TYPE 2 DIABETES MELLITUS 132 0.0039
388 INFUSION SITE ERYTHEMA 33 0.0039
389 DEEP VEIN THROMBOSIS 254 0.0039
390 TOOTH FRACTURE 43 0.0039
391 EAR DISCOMFORT 40 0.0039
392 PROCTALGIA 25 0.0039
393 LOCALISED INFECTION 94 0.0039
394 FLUSHING 395 0.0039
395 RENAL TUBULAR NECROSIS 38 0.0039
396 BLOOD PRESSURE ABNORMAL 77 0.0039
397 APHONIA 54 0.0039
398 SARS-COV-2 TEST POSITIVE 51 0.0039
399 SWOLLEN TONGUE 120 0.0038
400 HAEMATOCHEZIA 212 0.0038
401 RENAL FAILURE ACUTE 163 0.0038
402 SOMNOLENCE 773 0.0038
403 BRONCHITIS 284 0.0038
404 DYSSTASIA 112 0.0038
405 PRODUCTIVE COUGH 183 0.0038
406 PRODUCT COMPLAINT 97 0.0038
407 OSTEOPOROSIS 157 0.0038
408 INFUSION SITE SWELLING 24 0.0038
409 EYE INFECTION 43 0.0038
410 FOOT FRACTURE 72 0.0038
411 DEPRESSION 863 0.0038
412 ACTIVITIES OF DAILY LIVING IMPAIRED 75 0.0038
413 LYMPHADENOPATHY 134 0.0038
414 HEPATIC CIRRHOSIS 71 0.0038
415 RESPIRATORY TRACT CONGESTION 60 0.0038
416 ANXIETY 1074 0.0038
417 CONJUNCTIVITIS 70 0.0038
418 GASTROENTERITIS VIRAL 68 0.0038
419 FOOD ALLERGY 29 0.0038
420 SUNBURN 28 0.0038
421 PRODUCT USE ISSUE 705 0.0037
422 THERAPEUTIC PRODUCT EFFECT DECREASED 168 0.0037
423 IMPAIRED WORK ABILITY 80 0.0037
424 NERVOUSNESS 195 0.0037
425 CORONARY ARTERY DISEASE 113 0.0037
426 RHINITIS 30 0.0037
427 WHEEZING 220 0.0037
428 MOUTH ULCERATION 78 0.0037
429 WRONG PRODUCT ADMINISTERED 25 0.0037
430 DISEASE RECURRENCE 176 0.0037
431 FEELING COLD 103 0.0037
432 PRURITUS GENERALISED 80 0.0037
433 LABORATORY TEST ABNORMAL 109 0.0037
434 ANHEDONIA 97 0.0037
435 HAEMORRHOIDS 72 0.0037
436 INCONTINENCE 39 0.0037
437 SECRETION DISCHARGE 46 0.0037
438 VIRAL INFECTION 122 0.0037
439 OESOPHAGITIS 40 0.0037
440 BLINDNESS TRANSIENT 27 0.0037
441 NASAL CONGESTION 215 0.0037
442 BONE PAIN 214 0.0036
443 HEPATIC ENZYME INCREASED 249 0.0036
444 CONSTIPATION 796 0.0036
445 BLOOD CALCIUM DECREASED 41 0.0036
446 CONDITION AGGRAVATED 1108 0.0036
447 RASH GENERALISED 94 0.0036
448 OSTEOPENIA 55 0.0036
449 EYE DISORDER 119 0.0036
450 CONCUSSION 28 0.0036
451 WHITE BLOOD CELL COUNT INCREASED 138 0.0036
452 CHROMATURIA 81 0.0036
453 LIMB DISCOMFORT 111 0.0036
454 LIVER FUNCTION TEST INCREASED 77 0.0036
455 CARDIOMEGALY 44 0.0036
456 MYALGIA 608 0.0036
457 POLLAKIURIA 149 0.0036
458 BREAST PAIN 38 0.0036
459 DIZZINESS 1769 0.0035
460 MUSCULAR WEAKNESS 403 0.0035
461 DRY EYE 177 0.0035
462 NAIL DISORDER 31 0.0035
463 ANGINA UNSTABLE 23 0.0035
464 BLOOD CALCIUM INCREASED 31 0.0035
465 FATIGUE 2748 0.0035
466 SYSTEMIC LUPUS ERYTHEMATOSUS 125 0.0035
467 FLANK PAIN 33 0.0035
468 HAIR DISORDER 29 0.0035
469 HAIR TEXTURE ABNORMAL 47 0.0035
470 LACERATION 33 0.0035
471 STEVENS-JOHNSON SYNDROME 78 0.0035
472 SOMNAMBULISM 23 0.0035
473 NAUSEA 2770 0.0035
474 BLEPHAROSPASM 22 0.0035
475 RASH MACULAR 122 0.0035
476 THINKING ABNORMAL 65 0.0035
477 ABDOMINAL DISTENSION 364 0.0035
478 COUGH 975 0.0035
479 GENERAL SYMPTOM 26 0.0035
480 CYST 43 0.0035
481 HYSTERECTOMY 30 0.0035
482 VITREOUS FLOATERS 34 0.0035
483 FEAR 93 0.0035
484 BLOOD IRON DECREASED 41 0.0035
485 ABSCESS 55 0.0034
486 DISABILITY 68 0.0034
487 SLUGGISHNESS 35 0.0034
488 PAIN IN JAW 97 0.0034
489 CENTRAL NERVOUS SYSTEM LESION 47 0.0034
490 MOUTH HAEMORRHAGE 25 0.0034
491 INFLUENZA 380 0.0034
492 PALPITATIONS 399 0.0034
493 HYPERTENSION 720 0.0034
494 CHEST DISCOMFORT 348 0.0034
495 CHILLS 397 0.0034
496 LOWER GASTROINTESTINAL HAEMORRHAGE 25 0.0034
497 HAIR COLOUR CHANGES 42 0.0034
498 MULTIPLE SCLEROSIS 161 0.0034
499 AMNESIA 219 0.0034
500 HEART RATE IRREGULAR 76 0.0034
501 ILL-DEFINED DISORDER 204 0.0034
502 HYPERSOMNIA 96 0.0033
503 BEDRIDDEN 44 0.0033
504 ATRIAL SEPTAL DEFECT 28 0.0033
505 MULTIPLE SCLEROSIS RELAPSE 229 0.0033
506 RESPIRATION ABNORMAL 23 0.0033
507 INSURANCE ISSUE 51 0.0033
508 COVID-19 585 0.0033
509 BLINDNESS UNILATERAL 47 0.0033
510 CYSTITIS 106 0.0033
511 SKIN FISSURES 65 0.0033
512 UVEITIS 45 0.0033
513 VERTIGO 202 0.0033
514 SENSORY DISTURBANCE 53 0.0033
515 TENDON PAIN 25 0.0033
516 MASS 46 0.0033
517 HYPERAESTHESIA 27 0.0033
518 PERIPHERAL COLDNESS 45 0.0033
519 BLOOD TEST ABNORMAL 46 0.0033
520 BRAIN FOG 51 0.0033
521 ABDOMINAL PAIN 756 0.0032
522 PELVIC PAIN 59 0.0032
523 INTERNAL HAEMORRHAGE 37 0.0032
524 SKIN DISORDER 108 0.0032
525 HYPOKINESIA 47 0.0032
526 LIVE BIRTH 27 0.0032
527 LYMPHOCYTE COUNT DECREASED 57 0.0032
528 BLADDER DISORDER 32 0.0032
529 SKIN DISCOLOURATION 148 0.0032
530 WEIGHT INCREASED 721 0.0032
531 KIDNEY INFECTION 63 0.0032
532 MOVEMENT DISORDER 103 0.0032
533 TASTE DISORDER 65 0.0032
534 DIZZINESS POSTURAL 31 0.0032
535 EPISTAXIS 239 0.0032
536 CELLULITIS 161 0.0032
537 EATING DISORDER 68 0.0032
538 CHOLECYSTITIS 38 0.0032
539 PRODUCT ADMINISTRATION INTERRUPTED 25 0.0032
540 COORDINATION ABNORMAL 44 0.0032
541 DECREASED ACTIVITY 34 0.0031
542 FUNGAL INFECTION 105 0.0031
543 MENSTRUAL DISORDER 26 0.0031
544 MELAENA 69 0.0031
545 HEMIPARESIS 53 0.0031
546 BLOOD MAGNESIUM DECREASED 27 0.0031
547 HEPATITIS 80 0.0031
548 CHRONIC KIDNEY DISEASE 237 0.0031
549 MALAISE 1366 0.0031
550 PRURITUS 1194 0.0031
551 NEPHROPATHY 29 0.0031
552 PULMONARY EMBOLISM 295 0.0031
553 DIARRHOEA HAEMORRHAGIC 29 0.0031
554 MADAROSIS 36 0.0031
555 KNEE ARTHROPLASTY 65 0.0031
556 VENTRICULAR EXTRASYSTOLES 32 0.0031
557 BASAL CELL CARCINOMA 48 0.0031
558 HAEMATOCRIT DECREASED 61 0.0031
559 EYE HAEMORRHAGE 41 0.0031
560 ASTHMA 347 0.0031
561 PHARYNGEAL SWELLING 30 0.0031
562 CHOLECYSTECTOMY 35 0.0031
563 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 52 0.0031
564 NERVE INJURY 34 0.0031
565 SPUTUM DISCOLOURED 29 0.0031
566 MEMORY IMPAIRMENT 420 0.0031
567 LACRIMATION INCREASED 92 0.0030
568 RASH PRURITIC 164 0.0030
569 TRANSIENT ISCHAEMIC ATTACK 102 0.0030
570 VISION BLURRED 413 0.0030
571 VOMITING 1414 0.0030
572 HEPATIC STEATOSIS 56 0.0030
573 DIPLOPIA 78 0.0030
574 CRYING 109 0.0030
575 TUBULOINTERSTITIAL NEPHRITIS 56 0.0030
576 QUALITY OF LIFE DECREASED 40 0.0030
577 OEDEMA PERIPHERAL 363 0.0030
578 SQUAMOUS CELL CARCINOMA 28 0.0030
579 DYSPNOEA EXERTIONAL 112 0.0030
580 RED BLOOD CELL COUNT DECREASED 85 0.0030
581 OPTIC NEURITIS 27 0.0030
582 LOW DENSITY LIPOPROTEIN INCREASED 23 0.0030
583 ANAPHYLACTIC REACTION 164 0.0030
584 SPINAL DISORDER 28 0.0030
585 GOUT 53 0.0030
586 COLD SWEAT 52 0.0029
587 GASTROENTERITIS 43 0.0029
588 ILLNESS 303 0.0029
589 ANGINA PECTORIS 84 0.0029
590 WEIGHT DECREASED 817 0.0029
591 ARTERIAL OCCLUSIVE DISEASE 23 0.0029
592 RASH 1273 0.0029
593 WRONG TECHNIQUE IN DRUG USAGE PROCESS 106 0.0029
594 RESPIRATORY DISORDER 87 0.0029
595 SPINAL COMPRESSION FRACTURE 24 0.0029
596 URINARY INCONTINENCE 86 0.0029
597 URINARY TRACT INFECTION 495 0.0029
598 BLOOD ALBUMIN DECREASED 23 0.0029
599 ASTHENIA 1090 0.0029
600 ABNORMAL DREAMS 80 0.0029
601 RENAL CYST 23 0.0029
602 ANAL INCONTINENCE 26 0.0029
603 EYE DISCHARGE 30 0.0029
604 RASH ERYTHEMATOUS 138 0.0029
605 AGEUSIA 72 0.0029
606 TREMOR 477 0.0029
607 HUNGER 40 0.0029
608 OBSESSIVE-COMPULSIVE DISORDER 23 0.0029
609 C-REACTIVE PROTEIN INCREASED 104 0.0029
610 OCULAR DISCOMFORT 32 0.0028
611 GROIN PAIN 25 0.0028
612 PYREXIA 983 0.0028
613 OEDEMA 154 0.0028
614 PRESYNCOPE 69 0.0028
615 DEPRESSED MOOD 150 0.0028
616 ANAPHYLACTIC SHOCK 73 0.0028
617 EUPHORIC MOOD 29 0.0028
618 LUNG INFILTRATION 25 0.0028
619 DEAFNESS 74 0.0028
620 DIARRHOEA 1824 0.0028
621 MUSCLE TWITCHING 65 0.0028
622 IMMUNODEFICIENCY 42 0.0028
623 PULMONARY FIBROSIS 54 0.0028
624 ORAL CANDIDIASIS 37 0.0028
625 THERAPEUTIC RESPONSE SHORTENED 93 0.0028
626 METASTASES TO BONE 46 0.0028
627 HERPES ZOSTER 161 0.0028
628 MENORRHAGIA 55 0.0028
629 GASTROINTESTINAL HAEMORRHAGE 234 0.0028
630 THIRST 50 0.0028
631 HERNIA 54 0.0028
632 ABASIA 69 0.0028
633 MOOD SWINGS 89 0.0028
634 CATARACT 166 0.0028
635 IMPAIRED GASTRIC EMPTYING 38 0.0028
636 ALOPECIA 547 0.0028
637 DISTURBANCE IN ATTENTION 150 0.0028
638 DYSPHONIA 162 0.0028
639 ABDOMINAL PAIN LOWER 70 0.0028
640 WHITE BLOOD CELL COUNT DECREASED 300 0.0028
641 VAGINAL DISCHARGE 28 0.0028
642 DELIRIUM 96 0.0028
643 RESPIRATORY TRACT INFECTION 72 0.0028
644 MUSCLE ATROPHY 35 0.0028
645 OSTEOMYELITIS 50 0.0028
646 FEEDING DISORDER 56 0.0028
647 URINARY RETENTION 92 0.0028
648 INFECTION 395 0.0027
649 FACE OEDEMA 46 0.0027
650 SUPRAVENTRICULAR TACHYCARDIA 26 0.0027
651 RESPIRATORY RATE INCREASED 24 0.0027
652 NEUROPATHY PERIPHERAL 257 0.0027
653 INJECTION SITE INDURATION 35 0.0027
654 CORONARY ARTERY OCCLUSION 37 0.0027
655 METRORRHAGIA 46 0.0027
656 ANOSMIA 39 0.0027
657 DECREASED APPETITE 625 0.0027
658 GENERAL PHYSICAL HEALTH DETERIORATION 311 0.0027
659 HEAD INJURY 85 0.0027
660 WRIST FRACTURE 32 0.0027
661 EYELID PTOSIS 27 0.0027
662 IMMUNE SYSTEM DISORDER 35 0.0027
663 SPEECH DISORDER 139 0.0027
664 TOOTH EXTRACTION 33 0.0026
665 THERAPY CHANGE 26 0.0026
666 ANOREXIA 34 0.0026
667 ERYTHEMA 542 0.0026
668 FALL 875 0.0026
669 OCULAR HYPERAEMIA 124 0.0026
670 PLATELET COUNT INCREASED 34 0.0026
671 DIVERTICULITIS 72 0.0026
672 BODY TEMPERATURE INCREASED 53 0.0026
673 LEUKOCYTOSIS 47 0.0026
674 RENAL INJURY 77 0.0026
675 ERUCTATION 50 0.0026
676 DYSPNOEA 1462 0.0026
677 PULMONARY CONGESTION 34 0.0026
678 END STAGE RENAL DISEASE 47 0.0026
679 GASTROINTESTINAL INFECTION 23 0.0026
680 KNEE OPERATION 25 0.0025
681 UNEVALUABLE EVENT 192 0.0025
682 HYPOTHYROIDISM 81 0.0025
683 EYE PRURITUS 85 0.0025
684 OXYGEN SATURATION DECREASED 142 0.0025
685 PROCEDURAL PAIN 70 0.0025
686 BRONCHOSPASM 36 0.0025
687 EYE INFLAMMATION 24 0.0025
688 THERAPY NON-RESPONDER 113 0.0025
689 ACCIDENT 30 0.0025
690 INCREASED APPETITE 48 0.0025
691 MALNUTRITION 28 0.0025
692 SKIN HAEMORRHAGE 37 0.0025
693 BLOOD SODIUM DECREASED 47 0.0025
694 HAEMOGLOBIN DECREASED 255 0.0025
695 TOXIC SKIN ERUPTION 25 0.0025
696 SPLENOMEGALY 29 0.0025
697 PRODUCT SUBSTITUTION ISSUE 142 0.0025
698 CONFUSIONAL STATE 398 0.0025
699 IRRITABILITY 148 0.0025
700 MOOD ALTERED 67 0.0025
701 RENAL FAILURE 326 0.0025
702 INJECTION SITE URTICARIA 60 0.0024
703 HAEMOPTYSIS 68 0.0024
704 SMALL INTESTINAL OBSTRUCTION 30 0.0024
705 DEHYDRATION 325 0.0024
706 TENDON RUPTURE 30 0.0024
707 BLOOD POTASSIUM DECREASED 73 0.0024
708 ANGER 82 0.0024
709 OVERDOSE 523 0.0024
710 APHASIA 73 0.0024
711 PULMONARY MASS 36 0.0024
712 POOR VENOUS ACCESS 25 0.0024
713 SUICIDAL IDEATION 221 0.0024
714 FISTULA 27 0.0024
715 THYROID DISORDER 37 0.0024
716 PREGNANCY 48 0.0024
717 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 431 0.0024
718 NOCTURIA 29 0.0024
719 INJECTION SITE RASH 73 0.0024
720 ACCIDENTAL OVERDOSE 87 0.0024
721 PRODUCT QUALITY ISSUE 323 0.0024
722 ALANINE AMINOTRANSFERASE INCREASED 146 0.0024
723 INJECTION SITE DISCOMFORT 25 0.0024
724 BLOOD ALKALINE PHOSPHATASE INCREASED 59 0.0024
725 ACUTE MYOCARDIAL INFARCTION 70 0.0024
726 INTENTIONAL OVERDOSE 152 0.0024
727 PRODUCT DOSE OMISSION IN ERROR 67 0.0024
728 UPPER LIMB FRACTURE 47 0.0024
729 PRESCRIBED UNDERDOSE 47 0.0024
730 APPENDICITIS 22 0.0024
731 SPINAL OPERATION 29 0.0024
732 DRUG TOXICITY 32 0.0023
733 NEUTROPHIL COUNT INCREASED 24 0.0023
734 INCORRECT DOSE ADMINISTERED 535 0.0023
735 EMOTIONAL DISTRESS 283 0.0023
736 ARTERIOSCLEROSIS 22 0.0023
737 APATHY 34 0.0023
738 LETHARGY 134 0.0023
739 BLOOD TRIGLYCERIDES INCREASED 41 0.0023
740 VISUAL IMPAIRMENT 287 0.0023
741 BLOOD COUNT ABNORMAL 35 0.0023
742 STAPHYLOCOCCAL INFECTION 76 0.0023
743 EMOTIONAL DISORDER 71 0.0023
744 NODULE 30 0.0023
745 THERAPY CESSATION 118 0.0023
746 SKIN LESION 63 0.0023
747 THROMBOSIS 184 0.0023
748 DYSARTHRIA 86 0.0023
749 INTENTIONAL DOSE OMISSION 65 0.0023
750 SCRATCH 24 0.0023
751 COGNITIVE DISORDER 106 0.0023
752 SKIN EXFOLIATION 191 0.0023
753 MACULAR DEGENERATION 27 0.0023
754 PSORIASIS 294 0.0022
755 WITHDRAWAL SYNDROME 94 0.0022
756 GLAUCOMA 43 0.0022
757 MATERNAL EXPOSURE DURING PREGNANCY 199 0.0022
758 PANCREATITIS 118 0.0022
759 VASCULITIS 26 0.0022
760 HYPOKALAEMIA 103 0.0022
761 SKIN INFECTION 25 0.0022
762 IMPAIRED QUALITY OF LIFE 32 0.0022
763 DRY SKIN 295 0.0022
764 PARANOIA 38 0.0022
765 CANDIDA INFECTION 37 0.0022
766 ATAXIA 26 0.0022
767 EYE IRRITATION 126 0.0022
768 MENTAL IMPAIRMENT 53 0.0022
769 BLOOD BILIRUBIN INCREASED 59 0.0022
770 FLUID RETENTION 111 0.0022
771 HAEMORRHAGE 228 0.0022
772 EMPHYSEMA 22 0.0022
773 PRODUCT ADMINISTRATION ERROR 44 0.0022
774 FULL BLOOD COUNT ABNORMAL 23 0.0022
775 PSYCHOMOTOR HYPERACTIVITY 36 0.0022
776 BLOOD PRESSURE DECREASED 144 0.0022
777 PARALYSIS 31 0.0022
778 HIP FRACTURE 69 0.0021
779 BACTERIAL INFECTION 40 0.0021
780 HYPOACUSIS 92 0.0021
781 PLATELET COUNT DECREASED 227 0.0021
782 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 39 0.0021
783 INJECTION SITE BRUISING 169 0.0021
784 SINUS TACHYCARDIA 30 0.0021
785 HYPOPHAGIA 54 0.0021
786 ECONOMIC PROBLEM 32 0.0021
787 TREATMENT FAILURE 174 0.0021
788 ACNE 157 0.0021
789 SYNCOPE 206 0.0021
790 ANAEMIA 392 0.0021
791 PLEURAL EFFUSION 125 0.0021
792 INJECTION SITE REACTION 141 0.0020
793 PANCREATITIS ACUTE 46 0.0020
794 INJECTION SITE WARMTH 42 0.0020
795 LOSS OF CONSCIOUSNESS 261 0.0020
796 BLINDNESS 83 0.0020
797 ADVERSE REACTION 27 0.0020
798 MEDICATION ERROR 113 0.0020
799 LIVER FUNCTION TEST ABNORMAL 59 0.0020
800 MYDRIASIS 26 0.0020
801 ECZEMA 106 0.0020
802 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 144 0.0020
803 GENERALISED OEDEMA 25 0.0020
804 SKIN ULCER 52 0.0020
805 CONVULSION 115 0.0020
806 INJECTION SITE ERYTHEMA 249 0.0020
807 DERMATITIS 42 0.0020
808 SPINAL FRACTURE 40 0.0020
809 NEOPLASM PROGRESSION 69 0.0020
810 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 34 0.0020
811 PNEUMONITIS 54 0.0020
812 DISORIENTATION 78 0.0020
813 RESTLESSNESS 72 0.0020
814 SUICIDE ATTEMPT 119 0.0020
815 INCORRECT DRUG ADMINISTRATION DURATION 55 0.0020
816 PALLOR 53 0.0019
817 CARDIAC DISORDER 182 0.0019
818 ASPARTATE AMINOTRANSFERASE INCREASED 103 0.0019
819 BLOOD UREA INCREASED 32 0.0019
820 OSTEONECROSIS OF JAW 47 0.0019
821 CEREBROVASCULAR ACCIDENT 321 0.0019
822 PAIN OF SKIN 51 0.0019
823 PNEUMONIA 613 0.0019
824 INJECTION SITE MASS 70 0.0019
825 FULL BLOOD COUNT DECREASED 38 0.0019
826 INJECTION SITE PRURITUS 126 0.0019
827 ACUTE RESPIRATORY FAILURE 36 0.0019
828 LUNG INFECTION 29 0.0019
829 AGITATION 137 0.0019
830 HALLUCINATION 140 0.0019
831 ADVERSE DRUG REACTION 166 0.0018
832 SURGERY 108 0.0018
833 INJECTION SITE DISCOLOURATION 23 0.0018
834 MENTAL DISORDER 80 0.0018
835 ERECTILE DYSFUNCTION 47 0.0018
836 DERMATITIS ALLERGIC 23 0.0018
837 HYPOTENSION 366 0.0018
838 MYOCARDIAL INFARCTION 318 0.0018
839 POST PROCEDURAL COMPLICATION 35 0.0018
840 INTENTIONAL DRUG MISUSE 38 0.0018
841 SKIN BURNING SENSATION 130 0.0018
842 THERAPEUTIC RESPONSE DECREASED 110 0.0018
843 SKIN CANCER 39 0.0018
844 DELUSION 28 0.0018
845 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 94 0.0018
846 INJECTION SITE SWELLING 138 0.0018
847 TACHYCARDIA 160 0.0018
848 DYSKINESIA 73 0.0018
849 BONE LOSS 27 0.0018
850 COLITIS 68 0.0018
851 DRUG ADMINISTRATION ERROR 55 0.0018
852 HEPATIC FAILURE 54 0.0018
853 SKIN IRRITATION 82 0.0018
854 HYPERGLYCAEMIA 65 0.0018
855 INTESTINAL OBSTRUCTION 67 0.0018
856 ACUTE KIDNEY INJURY 272 0.0018
857 RESPIRATORY DISTRESS 49 0.0018
858 BLOOD LACTATE DEHYDROGENASE INCREASED 28 0.0018
859 PNEUMOTHORAX 28 0.0018
860 MENTAL STATUS CHANGES 49 0.0018
861 HYPOXIA 62 0.0018
862 GAMMA-GLUTAMYLTRANSFERASE INCREASED 39 0.0018
863 DIABETES MELLITUS 134 0.0018
864 PRODUCT DOSE OMISSION ISSUE 516 0.0018
865 HAEMATURIA 60 0.0018
866 VAGINAL HAEMORRHAGE 76 0.0017
867 OFF LABEL USE 1527 0.0017
868 PRODUCT DOSE OMISSION 111 0.0017
869 ANGIOEDEMA 75 0.0017
870 DRUG-INDUCED LIVER INJURY 53 0.0017
871 COLON CANCER 25 0.0017
872 RASH MACULO-PAPULAR 37 0.0017
873 JAUNDICE 44 0.0016
874 PRODUCT AVAILABILITY ISSUE 37 0.0016
875 INJECTION SITE PAIN 496 0.0016
876 ABNORMAL BEHAVIOUR 64 0.0016
877 MENSTRUATION IRREGULAR 43 0.0016
878 CLOSTRIDIUM DIFFICILE INFECTION 35 0.0016
879 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 54 0.0016
880 INJECTION SITE HAEMORRHAGE 127 0.0016
881 MANIA 26 0.0016
882 ASCITES 46 0.0016
883 HALLUCINATION, VISUAL 33 0.0016
884 BLOOD CREATININE INCREASED 102 0.0016
885 ATRIAL FIBRILLATION 149 0.0015
886 HYPONATRAEMIA 86 0.0015
887 ACUTE RESPIRATORY DISTRESS SYNDROME 27 0.0015
888 CYANOSIS 24 0.0015
889 DRUG DOSE OMISSION 252 0.0015
890 ISCHAEMIC STROKE 27 0.0015
891 THERAPY INTERRUPTED 108 0.0015
892 SEIZURE 174 0.0015
893 NERVOUS SYSTEM DISORDER 47 0.0015
894 COAGULOPATHY 25 0.0015
895 APPLICATION SITE PAIN 33 0.0015
896 TOOTH LOSS 31 0.0015
897 CARDIOMYOPATHY 22 0.0015
898 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 34 0.0015
899 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 294 0.0014
900 DEPRESSED LEVEL OF CONSCIOUSNESS 57 0.0014
901 METABOLIC ACIDOSIS 46 0.0014
902 UNDERDOSE 104 0.0014
903 DISEASE PROGRESSION 168 0.0014
904 BLOOD POTASSIUM INCREASED 23 0.0014
905 VISUAL ACUITY REDUCED 47 0.0014
906 CHOLESTASIS 27 0.0014
907 DRUG INTERACTION 223 0.0014
908 ADVERSE EVENT 129 0.0014
909 CEREBRAL INFARCTION 34 0.0014
910 DRUG LEVEL INCREASED 23 0.0014
911 HAEMATOMA 36 0.0014
912 PHARMACEUTICAL PRODUCT COMPLAINT 36 0.0014
913 INCORRECT PRODUCT ADMINISTRATION DURATION 30 0.0014
914 PULMONARY OEDEMA 62 0.0014
915 CARDIOVASCULAR DISORDER 35 0.0014
916 DEMENTIA 38 0.0014
917 EXPOSURE DURING PREGNANCY 84 0.0014
918 BONE DENSITY DECREASED 42 0.0013
919 PNEUMONIA ASPIRATION 33 0.0013
920 THROMBOCYTOPENIA 147 0.0013
921 METASTASES TO LIVER 23 0.0013
922 TREATMENT NONCOMPLIANCE 71 0.0013
923 RENAL IMPAIRMENT 108 0.0013
924 BLOOD GLUCOSE INCREASED 242 0.0013
925 LEUKOPENIA 64 0.0013
926 NEUTROPHIL COUNT DECREASED 52 0.0013
927 CEREBRAL HAEMORRHAGE 45 0.0013
928 AMENORRHOEA 22 0.0013
929 PERICARDIAL EFFUSION 29 0.0013
930 NEUTROPENIA 167 0.0012
931 DERMATITIS ATOPIC 63 0.0012
932 TRANSAMINASES INCREASED 26 0.0012
933 HEPATOTOXICITY 26 0.0012
934 RESPIRATORY FAILURE 84 0.0012
935 SEPTIC SHOCK 50 0.0011
936 EPILEPSY 35 0.0011
937 ARRHYTHMIA 54 0.0011
938 AGGRESSION 57 0.0011
939 PRODUCT PRESCRIBING ERROR 27 0.0011
940 CARDIAC FAILURE CONGESTIVE 91 0.0011
941 SEPSIS 126 0.0011
942 PULMONARY HYPERTENSION 23 0.0011
943 PLASMA CELL MYELOMA 43 0.0011
944 APPLICATION SITE PRURITUS 25 0.0011
945 FEBRILE NEUTROPENIA 72 0.0011
946 ENCEPHALOPATHY 26 0.0011
947 DEVICE DISLOCATION 46 0.0011
948 COMA 50 0.0010
949 PSYCHOTIC DISORDER 31 0.0010
950 UNRESPONSIVE TO STIMULI 27 0.0010
951 MUCOSAL INFLAMMATION 27 0.0010
952 BRADYCARDIA 54 0.0010
953 BLOOD CREATINE PHOSPHOKINASE INCREASED 29 0.0010
954 ACCIDENTAL EXPOSURE TO PRODUCT 101 0.0010
955 NEOPLASM MALIGNANT 64 0.0010
956 DRUG WITHDRAWAL SYNDROME 84 0.0010
957 INTERNATIONAL NORMALISED RATIO INCREASED 27 0.0009
958 ABORTION SPONTANEOUS 37 0.0009
959 OSTEONECROSIS 30 0.0009
960 MALIGNANT NEOPLASM PROGRESSION 93 0.0009
961 BLOOD GLUCOSE DECREASED 43 0.0009
962 EXPOSURE VIA SKIN CONTACT 22 0.0008
963 APPLICATION SITE ERYTHEMA 22 0.0008
964 RHABDOMYOLYSIS 35 0.0008
965 PREMATURE BABY 25 0.0008
966 PANCYTOPENIA 46 0.0008
967 LUNG NEOPLASM MALIGNANT 33 0.0008
968 DEVICE ISSUE 72 0.0008
969 HYPERKALAEMIA 28 0.0008
970 DRUG EXPOSURE DURING PREGNANCY 27 0.0008
971 DRUG DEPENDENCE 126 0.0008
972 CARDIO-RESPIRATORY ARREST 32 0.0008
973 PRODUCT ADHESION ISSUE 27 0.0008
974 FEMUR FRACTURE 22 0.0007
975 FOETAL EXPOSURE DURING PREGNANCY 57 0.0007
976 DEVICE BREAKAGE 28 0.0007
977 HYPOGLYCAEMIA 33 0.0007
978 HOSPITALISATION 104 0.0007
979 BREAST CANCER 62 0.0007
980 PRODUCT STORAGE ERROR 57 0.0007
981 HEPATIC FUNCTION ABNORMAL 23 0.0006
982 DEVICE MALFUNCTION 43 0.0006
983 CARDIAC ARREST 49 0.0006
984 DRUG ABUSE 49 0.0006
985 NO ADVERSE EVENT 95 0.0005
986 TOXICITY TO VARIOUS AGENTS 87 0.0005
987 DEATH 438 0.0005
988 CARDIAC FAILURE 34 0.0004
989 DEVICE DIFFICULT TO USE 28 0.0004
990 DEPENDENCE 22 0.0004
991 PROSTATE CANCER 32 0.0004
992 COMPLETED SUICIDE 32 0.0004
993 BLADDER CANCER 22 0.0004